Search for: "BRISTOL-MYERS SQUIBB" Results 61 - 80 of 867
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2022, 11:45 am by luiza
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]
5 Dec 2021, 9:36 pm by Patent Docs
Elsby of Akin Gump will moderate a panel consisting of Paul Golian of Bristol Myers Squibb and Paula Fritsch of Amgen. [read post]
13 Nov 2021, 8:04 pm by Patent Docs
Serena Farquharson-Torres of Bristol-Myers Squibb Co.; Sophia Piliouras of Minority Corporate Counsel Association; Elaine Spector of Harrity & Harrity, LLP; and Christopher Suarez of Steptoe & Johnson LLP will provide practical insights and tips to lawyers who seek to improve their practices by becoming better stewards of diversity and inclusion in... [read post]
18 Sep 2021, 8:45 pm by Patent Docs
.; Henry Hadad of Bristol-Myers Squibb; Joshua Rosenkranz of Orrick, Herrington & Sutcliffe LLP; and John Whealan of The George Washington... [read post]
3 Sep 2021, 6:36 pm by Lawrence B. Ebert
Patent No. 6,967,208 (“the ’208 patent”): (1) “substituted with [N] R,” see Bristol-Myers Squibb Co. v. [read post]
30 Aug 2021, 12:27 pm by Mark Tabakman
The proper jurisdiction for these suits, as the Seyfarth post notes, became open to debate after a US Supreme Court 2017 decision in Bristol Myers Squibb v Superior Court. [read post]
20 Aug 2021, 9:58 am by Seyfarth Shaw LLP
By Lennon Haas and Noah Finkel Seyfarth Synopsis:  Since the Supreme Court’s 2017 decision in Bristol-Myers Squibb Co. v. [read post]
18 Aug 2021, 12:07 pm by jeffreynewmanadmin
 California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. [read post]
15 Aug 2021, 11:51 pm by Radhi Shah (USC Gould School of Law)
Bristol-Myers Squibb   The following case illustrates licence sought for Sprycel® which is used in cancer treatment On March 4, 2013 the Controller rejected BDR Pharmaceuticals’ (BDR) application for a compulsory license for the cancer drug Sprycel®. [read post]
13 Aug 2021, 6:00 am by Daily Record Staff
Morgan State University was one of five historically Black colleges and universities chosen by Bristol Myers Squibb to create custom biopharma educational programming and increase recruitment of Black talent in the biopharma industry. [read post]
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January 2016 16 April 2015… [read post]
25 Jun 2021, 4:15 am by Logan Murr
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
25 May 2021, 12:45 pm by Paul Caron
Burke (Florida) presents Bristol-Myers’ Disappearing Gain at Florida today as part of its Summer Virtual Workshop Series: Recently, an alleged tax shelter involving Bristol-Myers Squibb (Bristol) accidentally came to light and then quickly disappeared from public view. [read post]
25 May 2021, 3:00 am by Avery Welker
., International Shoe, Bristol-Myers Squibb, Daimler A.G., etc.). [read post]
17 May 2021, 1:12 pm by Dennis Crouch
“And Trimble is headquartered in California, connecting California to Trimble’s claims, which is a consideration the Court in Ford found relevant in distinguishing its earlier decision in Bristol-Myers. [read post]
30 Apr 2021, 10:23 am by jeffreynewmanadmin
[…] The post Bristol-Myers Squibb Pays $75 Million to settle False Claims Act case on underpayment of drug rebates owed through medicaid appeared first on Newman & Shapiro. [read post]
22 Apr 2021, 7:02 am by David W.S. Lieberman
According to the government, Bristol-Myers Squibb underreported AMPs for a number of its drugs. [read post]